Subchronic Exposure to Arsenic Through Drinking Water Alters Expression of Cancer-Related Genes in Rat Liver

Abstract

Although arsenic exposure causes liver disease and/or hepatoma, little is known about molecular mechanisms of arsenic-induced liver toxicity or carcinogenesis. We investigated the effects of arsenic on expression of cancer-related genes in a rat liver following subchronic exposure to sodium arsenate (1, 10, 100 ppm in drinking water), by using real-time quantitative RT-PCR and immunohistochemical analyses. Arsenic accumulated in the rat liver dose-dependently and caused hepatic histopathological changes, such as disruption of hepatic cords, sinusoidal dilation, and fatty infiltration. A 1-month exposure to arsenic significantly increased hepatic mRNA levels of cyclin D1 (10 ppm), ILK (1 ppm), and p27Kip1 (10 ppm), whereas it reduced mRNA levels of PTEN (1 ppm) and β-catenin (100 ppm). In contrast, a 4-month arsenic exposure showed increased mRNA expression of cyclin D1 (100 ppm), ILK (1 ppm), and p27Kip1 (1 and 10 ppm), and decreased expression of both PTEN and β-catenin at all 3 doses. An immunohistochemical study revealed that each protein expression accords closely with each gene expression of mRNA level. In conclusion, subchronic exposure to inorganic arsenate caused pathological changes and altered expression of cyclin D1, p27Kip1, ILK, PTEN, and β-catenin in the liver. This implies that arsenic liver toxicity involves disturbances of some cancer-related molecules.

Keywords

Arsenate liver toxicity cyclin D1 p27Kip1 ILK PTEN β-catenin.

References

Ali, I.U. , L.M. Schriml , and M. Dean (1999). “Mutational Spectra of PTEN/MMAC1 Gene: A Tumor Suppressor with Lipid Phosphatase Activity. J Natl Cancer Inst 91: 1922—32.

Andrew, A.S. , A.J. Warren , A. Barchowsky , K.A. Temple , L. Klei , N.V. Soucy , K.A. O'Hara , and J.W. Hamilton (2003). “Genomic and Proteomic Profiling of Responses to Toxic Metals in Human Lung Cells.” Environ Health Perspect 111(6): 825—35.

Bates, M.N. , A.H. Smith , and C. Hopenhayn-Rich (1992). “Arsenic Ingestion and Internal Cancers: A Review.” Am J Epidemiol 135: 462—76.

Bae, D.S. , R.J. Handa , R.S. Yang , and J.A. Campain (2003). “Gene Expression Patterns as Potential Molecular Biomarkers for Malignant Transformation in Human Keratinocytes Treated with MNNG, Arsenic, or a Metal Mixture.” Toxicol Sci 74(1): 32—42.

Bae, D.S. , W.H. Hanneman , R.S. Yang , and J.A. Campain (2002). “Characterization of Gene Expression Changes Associated with MNNG, Arsenic, or Metal Mixture Treatment in Human Keratinocytes: Application of cDNA Microarray Technology.” Environ Health Perspect 110 (Suppl 6): 931—41.

Ben-Ze'ev, A. and B. Geiger (1998). “Differential Molecular Interactions of Beta-Catenin and Plakoglobin in Adhesion, Signaling and Cancer.” Curr Opin Cell Biol 10: 629—39.

Byron, W.R. , G.W. Bierbower , J.B. Brouwer , and W.H. Hansen (1967). “Pathologic Changes in Rats and Dogs from Two-Year Feeding of Sodium Arsenite or Sodium Arsenate” Toxicol Appl Pharmacol 10: 132—47.

Chen, C.J. , C.W. Chen , M.M. Wu , and T.L. Kuo (1992). “Cancer Potential in Liver, Lung, Bladder and Kidney due to Ingested Inorganic Arsenic in Drinking Water.” Br J Cancer 66: 888—92.

Chen, C.J. , T.L. Kuo , and M.M. Wu (1988). “Arsenic and Cancers. Lancet 1: 414—5.

10.

Chen, H. , J. Liu , C.Q. Zhao , B.A. Diwan , B.A. Merrick , and M.P. Waalkes (2001). “Association of c-myc Overexpression and Hyperproliferation with Arsenite-Induced Malignant Transformation.” Toxicol Appl Pharmacol 175: 260—8.

11.

Chen, H. , J. Liu , and B.A. Merrick , M.P. Waalkes (2001). “Genetic Events Associated with Arsenic-Induced Malignant Transformation: Applications of cDNA Microarray Technology.” Mol Carcinog 30: 79—87.

12.

Chiou, H.Y. , Y.M. Hsueh , K.F. Liaw , S.F. Horng , M.H. Chiang , Y.S. Pu , J.S. Lin , C.H. Huang , and C.J. Chen (1995). “Incidence of Internal Cancers and Ingested Inorganic Arsenic: A Seven-Year Follow-Up Study in Taiwan.” Cancer Res 55: 1296—300.

13.

Chiou, H.Y. , S.T. Chiou , Y.H. Hsu , Y.L. Chou , C.H. Tseng , M.L. Wei , and C.J. Chen (2001). “Incidence of Transitional Cell Carcinoma and Arsenic in Drinking Water: A Follow-up Study of 8,102 Residents in an Arseniasis-Endemic Area in Northeastern Taiwan.” Am J Epidemiol 153: 411—8.

14.

Counts, J.L. and J.I. Goodman (1995). “Alterations in DNA Methylation May Play a Variety of Roles in Carcinogenesis.” Cell 83: 13—5.

15.

Dedhar, S. (2000). “Cell-Substrate Interactions and Signaling Through ILK.” Curr Opin Cell Biol 12: 250—6.

16.

Germolec, D.R. , T. Yoshida , K. Gaido , J.L. Wilmer , P.P. Simeonova , F. Kayama , F. Burleson , W. Dong , R.W. Lange , and M.I. Luster (1996). “Arsenic Induces Overexpression of Growth Factors in Human Keratinocytes.” Toxicol Appl Pharmacol 141: 308—18.

17.

Goering, P.L. , H.V. Aposhian , M.J. Mass , M. Cebrian , B.D. Beck , and M.P. Waalkes (1999). “The Enigma of Arsenic Carcinogenesis: Role of Metabolism.” Toxicol Sci 49: 5—14.

18.

Graff, J.R. , J.A. Deddens , B.W. Konicek , B.M. Colligan , B.M. Hurst , H.W. Carter , and J.H. Carter (2001). “Integrin-Linked Kinase Expression Increases with Prostate Tumor Grade.” Clin Cancer Res 7: 1987—91.

19.

Guha Mazumder, D.N. (2001). “Arsenic and Liver Disease.” J Indian Med Assoc 99: 311, 314-5, 318—20.

20.

Hamadeh, H.K. , K.J. Trouba , R.P. Amin , C.A. Afshari , and D. Germolec (2002). “Coordination of Altered DNA Repair and Damage Pathways in Arsenite-Exposed Keratinocytes.” Toxicol Sci 69: 306—16.

21.

Hirano, S. , T. Shimada , J. Osugi , N. Kodama , and K.T. Suzuki (1994). “Pulmonary Clearance and Inflammatory Potency of Intratracheally Instilled or Acutely Inhaled Nickel Sulfate in Rats. ” Arch Toxicol 68: 548—54.

22.

Hirata, F. , S. Toyoshima , J. Axelrod , and M.J. Waxdel (1980). “Phospholipid Methylation: A Biochemical Signal Modulating Lymphocyte Mitogenesis.” Proc Natl Acad Sci USA 77: 862—865.

23.

Hui, A.M. , X. Cui , M. Makuuchi , X. Li , Y.Z. Shi , and T. Takayama (1999). “Decreased p27(Kip1) Expression and Cyclin D1 Overexpression, Alone and in Combination, Influence Recurrence and Survival of Patients with Resectable Duct Carcinoma.” Hepatology 30: 1167—73.

24.

Iarc. (1987) In IARC Monograghs on Evaluation of Carcinogenic Risks of Chemicals to Humans: Overall Evaluations of Carcinogenicity: An Updating of IARC Monograghs 1 to 42, Suppl. 7. World Health Organization, IARC, Lyon.

25.

Ito, Y. , N. Matsuura , M. Sakon , E. Miyoshi , K. Noda , T. Takeda , K. Umeshita , H. Nagano , S. Nakamori , K. Dono , M. Tsujimoto , M. Nakahara , K. Nakao , N. Taniguchi , and M. Monden (1999). “Expression and Prognostic Roles of the G1-S Modulators in Hepatocellular Carcinoma: p27 Independently Predicts the Recurrence.” Hepatology 30: 90—9.

26.

Jiang, W. , S.M. Kahn , P. Zhou , Y.J. Zhang , A.M. Cacace , A.S. Infante , S. Doi , R.M. Santella , and I.B. Weinstein (1993). “Overexpression of Cyclin D1 in Rat Fibroblasts Causes Abnormalities in Growth Control, Cell Cycle Progression and Gene Expression .” Oncogene 8: 3447—57.

27.

Kitchin, K.T. (2001). “Recent Advances in Arsenic Carcinogenesis: Modes of Action, Animal Model Systems, and Methylated Arsenic Metabolites .” Toxicol Appl Pharmacol 172: 249—61.

28.

Liu, D.N. , X.Z. Lu , B.L. Li , D.X. Zhou , F.X. Li , D.H. Zheng , and K.H. Wang (1992). “Clinical Analysis of 535 Cases of Chronic Arsenic Poisoning from Coal Burning” [in Chinese]. Chin J Med 31: 560—2.

29.

Liu, F. and K.Y. Jan (2000). “DNA Damage in Arsenite- and Cadmium-Treated Bovine Aortic Endothelial Cells.” Free Radic Biol Med 28: 55—63.

30.

Liu, S.X. , M. Athar , I. Lippai , C. Waldren , and T.K. Hei (2001). “Induction of Oxyradicals by Arsenic: Implication for Mechanism of Genotoxicity.” Proc Natl Acad Sci USA 98: 1643—8.

31.

Liu, J. , B. Zheng , H.V. Aposhian , Y. Zhou , M.L. Chen , A. Zhang , and M.P. Waalkes (2002). “Chronic Arsenic Poisoning from Burning High-Arsenic-Containing Coal in Guizhou, China.” Environ Health Perspect 110: 119— 22.

32.

Lloyd, R.V. , L.A. Erickson , L. Jin , E. Kulig , X. Qian , J.C. Cheville , and B.W. Scheithauer (1999). “p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers ” Am J Pathol 154: 313—23.

33.

Lu, T. , J. Liu , E.L. LeCluyse , Y.S. Zhou , M.L. Cheng , and M.P. Waalkes (2001). “Application of cDNA Microarray to the Study of Arsenic-Induced Liver Diseases in the Population of Guizhou, China.” Toxicol Sci 59(1):185—92

34.

Mass, M.J. , A. Tennant , B.C. Roop , W.R. Cullen , M. Styblo , D.J. Thomas , and A.D. Kligerman (2001). “Methylated Trivalent Arsenic Species are Genotoxic.” Chem Res Toxicol 14: 355—61.

35.

Mass, M.J. and L. Wang (1997). “Arsenic Alters Cytosine Methylation Patterns of the Promoter of the Tumor Suppressor Gene p53 in Human Lung Cells: A Model for a Mechanism of Carcinogenesis.” Mutat Res 386: 263—77.

36.

Mazumder, D.N. , J. Das Gupta , A. Santra , A. Pal , A. Ghose , and S. Sarkar (1998). “Chronic Arsenic Toxicity in West Bengal—The Worst Calamity in the World.” J Indian Med Assoc 96: 4—7, 18.

37.

Moore, L.E. , A.H. Smith , C. Eng , D. Kalman , S. DeVries , V. Bhargava , K. Chew , D. Moore , C. Ferreccio , O.A. Rey , and F.M. Waldman (2002). “Arsenic-Related Chromosomal Alterations in Bladder Cancer.” J Natl Cancer Inst 94: 1688—96.

38.

Mumtaz, M.M. , D.B. Tully , H.A. El-Masri , and C.T. De Rosa (2002). “Gene Induction Studies and Toxicity of Chemical Mixtures” Environ Health Perspect 110 (Suppl 6): 947—56

39.

National Research Council (NCR) (1999). National Research Council Report: Arsenic in the Drinking Water, National Academy Press, Washington, DC.

40.

Persad, S. , S. Attwell , V. Gray , M. Delcommenne , A. Troussard , J. Sanghera , and S. Dedhar (2000). “Inhibition of Integrin-Linked Kinase (ILK) Suppresses Activation of Protein Kinase B/Akt and Induces Cell Cycle Arrest and Apoptosis of PTEN-Mutant Prostate Cancer Cells.” Proc Natl Acad Sci USA 97: 3207—12.

41.

Pi, J. , H. Yamauchi , Y. Kumagai , G. Sun , T. Yoshida , H. Aikawa , C. Hopenhayn-Rich , and N. Shimojo (2002). “Evidence for Induction of Oxidative Stress Caused by Chronic Exposure of Chinese Residents to Arsenic Contained in Drinking Water.” Environ Health Perspect 110: 331—6.

42.

Qian, X. , L. Jin , E. Kulig , and R.V. Lloyd (1998). “DNA Methylation Regulates p27kip1 Expression in Rodent Pituitary Cell Lines.” Am J Pathol 153: 1475—82.

43.

Radeva, G. , T. Petrocelli , E. Behrend , C. Leung-Hagesteijn , J. Filmus , J. Slingerland , and S. Dedhar (1997). “Overexpression of the Integrin-Linked Kinase Promotes Anchorage-Independent Cell Cycle Progression. J Biol Chem 272: 13937—44.

44.

Rea, M.A. , J.P. Gregg , Q. Qin , M.A. Phillips , and R.H. Rice (2003). “Global Alteration of Gene Expression in Human Keratinocytes by Inorganic Arsenic Carcinogenesis 24(4): 747—56.

45.

Santra, A. , A. Maiti , S. Das , S. Lahiri , S.K. Charkaborty , and D.N. Mazumder (2000). “Hepatic Damage Caused by Chronic Arsenic Toxicity in Experimental Animals.” J Toxicol Clin Toxicol 38: 395—405.

46.

Sherr, C.J. (1996). “Cancer Cell Cycles.” Science 274: 1672—7.

47.

Simeonova, P.P. , S. Wang , W. Toriuma , V. Kommineni , J. Matheson , N. Unimye , F. Kayama , D. Harki , M. Ding , V. Vallyathan , and M.I. Luster (2000). “Arsenic Mediates Cell Proliferation and Gene Expression in the Bladder Epithelium: Association with Activating Protein-1 Transactivation. Cancer Res 60: 3445—53.

48.

Simpson, L. and R. Parsons (2001). “PTEN: Life as a Tumor Suppressor.” Exp Cell Res 264: 29—41.

49.

Soria, J.C. , H.Y. Lee , J.I. Lee , L. Wang , J.P. Issa , B.L. Kemp , D.D. Liu , J.M. Kurie , L. Mao , and F.R. Khuri (2002). “Lack of PTEN Expression in Non-Small Cell Lung Cancer Could be Related to Promoter Methylation.” Clin Cancer Res 8: 1178—84.

50.

Stambolic, V. (2002). “PTEN: A New Twist on Beta-Catenin? ” Trends Pharmacol Sci 23: 104—6.

51.

Vogt, B.L. and T.G. Rossman (2001). “Effects of Arsenite on p53, p21 and Cyclin D Expression in Normal Human Fibroblasts—A Possible Mechanism for Arsenite's Comutagenicity.” Mutat Res 478: 159— 68.

52.

Waalkes, M.P. , L.K. Keefer , and B.A. Diwan (2000). “Induction of Proliferative Lesions of the Uterus, Testes, and Liver in Swiss Mice Given Repeated Injections of Sodium Arsenate: Possible Estrogenic Mode of Action.” Toxicol Appl Pharmacol 166: 24—35.

53.

Waring, J.F. , R. Ciurlionis , R.A. Jolly , M. Heindel , and R.G. Ulrich (2001). “Microarray Analysis of Hepatotoxins in vitro Reveals a Correlation between Gene Expression Profiles and Mechanisms of Toxicity.” Toxicol Lett 120(1—3): 359—68.

54.

Waring, J.F. , R.A. Jolly , R. Ciurlionis , P.Y. Lum , J.T. Praestgaard , D.C. Morfitt , B. Buratto , C. Roberts , E. Schadt , and R.G. Ulrich (2001). “Clustering of Hepatotoxins Based on Mechanism of Toxicity Using Gene Expression Profiles.” Toxicol Appl Pharmacol 175(1): 28—42.

55.

Wu, C. , S.Y. Keightley , C. Leung-Hagesteijn , G. Radeva , M. Coppolino , S. Goicoechea , J.A. McDonald , and S. Dedhar (1998). “Integrin-Linked Protein Kinase Regulates Fibronectin Matrix Assembly, E-Cadherin Expression, and Tumorigenicity.” J Biol Chem 273: 528—36.

56.

Yamanaka, K. , H. Hayashi , M. Tachikawa , K. Kato , A. Hasegawa , N. Oku , and S. Okada (1997). “Metabolic Methylation is a Possible Genotoxicity-Enhancing Process of Inorganic Arsenics.” Mutat Res 394: 95— 101.

57.

Yih, L.H. , K. Peck , and T.C. Lee (2002). “Changes in Gene Expression Profiles of Human Fibroblasts in Response to Sodium Arsenite Treatment.” Carcinogenesis 23(5): 867—76.

58.

Yoganathan, T.N. , P. Costello , X. Chen , M. Jabali , J. Yan , D. Leung , Z. Zhang , A. Yee , S. Dedhar , and J. Sanghera (2000). “Integrin-Linked Kinase (ILK): A “Hot” Therapeutic Target.” Biochem Pharmaco 60: 1115—9.

59.

Zhao, C.Q. , M.R. Young , B.A. Diwan , T.P. Coogan , and M.P. Waalkes (1997). “Association of Arsenic-Induced Malignant Transformation with DNA Hypomethylation and Aberrant Gene Expression.” Proc Natl Acad Sci USA 94: 10907—12.

60.

Zheng, X.H. , G.S. Watts , S. Vaught , and A.J. Gandolfi (2003). “Low-Level Arsenite Induced Gene Expression in HEK293 Cells.” Toxicology 187(1): 39—48.